Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008)
- Status
- COMPLETED
- Phase
- PHASE2
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Invasive Fungal Infections in Patients Following Stem Cell Transplant
- Status
- COMPLETED
- Phase
- N/A
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Time to Extubation Using Sugammadex or Neostigmine
- Status
- COMPLETED
- Phase
- PHASE4
Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT
- Status
- RECRUITING
- Phase
- PHASE2
Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida
- Status
- COMPLETED
- Phase
- N/A
A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study to Evaluate D-1553 in Subjects With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-3655-001)
- Status
- TERMINATED
- Phase
- PHASE2
County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana
- Status
- COMPLETED
- Phase
- N/A
Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2